Amaroq Therapeutics
Auckland
About Amaroq Therapeutics
Amaroq Therapeutics is a biotechnology company that focuses on the development of next-generation cancer therapies. The company's research is centered around long non-coding RNAs, often referred to as the 'dark matter' of the human genome. These molecules, which were only recently discovered, are being explored for their potential in cancer treatment. Amaroq Therapeutics is developing novel cancer therapies that specifically target these long non-coding RNAs. The company's work is based on research spun out of the University of Otago in Dunedin, New Zealand.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: amaroqtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/amaroq-therapeutics-41692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.